Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02066571Phase 2Unknown
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease
Cognitive Ability, GeneralFreezing of GaitParkinson's Disease
Principalinvestigator
NCT06312800Phase 2Withdrawn
Acamprosate and Methazolamide for Essential Tremor
Essential Tremor
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Henry Ford Health System

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02066571Phase 2PrincipalInvestigator

Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease

Cognitive Ability, GeneralFreezing of GaitParkinson's Disease
Unknown
NCT06312800Phase 2PrincipalInvestigator

Acamprosate and Methazolamide for Essential Tremor

Essential Tremor
Withdrawn

All 2 trials loaded